Pharmacokinetics of factor IX in patients with haemophilia B. Methodological aspects and physiological interpretation.
about
New developments in the management of moderate-to-severe hemophilia BThe History of Clotting Factor Concentrates PharmacokineticsPharmacokinetics of plasma-derived and recombinant factor IX: using population pharmacokinetics with sparse sampling data needs further study.Stereospecific determination, chiral inversion in vitro and pharmacokinetics in humans of the enantiomers of thalidomide.Secondary prophylaxis with factor IX concentrates: continuous infusion.Pharmacokinetic allometric scaling of coagulation factors and tissue-type plasminogen activators.Implications of coagulation factor VIII and IX pharmacokinetics in the prophylactic treatment of haemophilia.Pharmacokinetics of plasma-derived and recombinant factor IX - implications for prophylaxis and on-demand therapy.Population pharmacokinetic modelling of recombinant factor IX Fc fusion protein (rFIXFc) in patients with haemophilia B.Population pharmacokinetics of plasma-derived factor IX: procedures for dose individualization.In vivo recovery with products of very high purity--assay discrepancies.Multidose pharmacokinetics of factor IX: implications for dosing in prophylaxis.Continuous infusion of intermediate-purity factor VIII in haemophilia A patients undergoing elective surgery.In vivo recovery of factor VIII and factor IX: intra- and interindividual variance in a clinical setting.A commentary on the differences in pharmacokinetics between recombinant and plasma-derived factor IX and their implications for dosing.Individualized factor IX dosing in two brothers: application of longitudinal pharmacokinetic modelling to optimize therapeutic benefit.Selective disruption of heparin and antithrombin-mediated regulation of human factor IX.The features of clearance in recombinant factor IX (BeneFIX(®) ).Pharmacokinetics of recombinant factor IX in relation to age of the patient: implications for dosing in prophylaxis.Population pharmacokinetics of plasma-derived factor IX in adult patients with haemophilia B: implications for dosing in prophylaxis.Pharmacokinetic analysis of plasma-derived and recombinant F IX concentrates in previously treated patients with moderate or severe hemophilia B.Population pharmacokinetics of recombinant factor VIII Fc fusion protein.Can haemophilic arthropathy be prevented?
P2860
Q26751323-FF01F01A-97E3-45E9-888B-CAB101BD3143Q30235127-7B554B53-2BF2-4B8D-B148-F0F03A95D09AQ30685072-0A0F9EB7-2A25-496C-AB45-C0D0597F21DEQ34058602-14F05D18-F4E2-4DB2-AD44-00E0DCDD1CFCQ37357215-E06972D1-586A-404D-965E-B997BD2423A7Q37517844-AD9E769F-5623-4EFE-A8B4-D7807395CA74Q37781837-F2048981-31B9-4FCA-B570-00F6020169D4Q38115812-3BE3D920-7C94-4ECE-970C-06A2C9428066Q38935228-33887938-2E7E-48EB-A64D-1AFB4BA197C2Q40066317-2F213800-A778-43BF-95C8-FED87D4F3902Q45855096-9CEE3885-DC9C-4D8C-9A9C-046BA66D0F83Q45855151-EFA23550-AE02-4342-8DF9-8EC6B2D7B2D3Q45861264-03EB80AA-827D-430F-B76C-2CA1561674BDQ45864852-D03DBA10-BFCD-4E48-9D21-B34B5BBD8789Q45866870-9A12DF82-5F71-4C48-93C0-2A0BA70AB5B4Q45870386-3254CAF1-6E68-4DEB-A669-ACAAB3439250Q45874726-B8D42914-6078-425E-A55D-745F06596CEEQ45874776-1C166680-E579-4EED-834D-0ACDE8D0AD76Q45875808-6FD33680-BE0F-4688-828C-56517C2277D0Q45876681-23F0EC20-4B60-4EBD-A458-04399151448AQ45884319-58435DFE-4212-4FEA-8CC5-8DCE21F1318FQ45885620-987E2AEC-8FEE-49BC-B16D-EE3D3DDA19B9Q45887428-A228B777-83AA-43E0-8956-978158319C95
P2860
Pharmacokinetics of factor IX in patients with haemophilia B. Methodological aspects and physiological interpretation.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh-hant
name
Pharmacokinetics of factor IX ...... physiological interpretation.
@en
Pharmacokinetics of factor IX ...... physiological interpretation.
@nl
type
label
Pharmacokinetics of factor IX ...... physiological interpretation.
@en
Pharmacokinetics of factor IX ...... physiological interpretation.
@nl
prefLabel
Pharmacokinetics of factor IX ...... physiological interpretation.
@en
Pharmacokinetics of factor IX ...... physiological interpretation.
@nl
P2093
P921
P356
P1476
Pharmacokinetics of factor IX ...... physiological interpretation.
@en
P2093
E Berntorp
M Carlsson
S Björkman
P2888
P304
P356
10.1007/BF00194400
P577
1994-01-01T00:00:00Z
P6179
1035874509